Developments in Wound Management Could Revolutionize Traditional Practices

By HospiMedica International staff writers
Posted on 28 Jul 2009
Understanding the problems caused by the infection of surgical wounds and their associated health implications in terms of quandaries that impose severe demands on healthcare resources could provide an alternative to traditional wound healing practices.

To address these issues, and others affecting wound management, the Royal Pharmaceutical Society of Great Britain (RPSGB, London, United Kingdom) is holding a special one-day conference on recent developments in wound management, including new intelligent biomaterials and novel antimicrobials. The conference aims to deliver world-class research solutions to strategic wound management and will bring delegates up to date with recent developments in this field. Other topics and presentations to be discussed at the conference include novel antimicrobial materials, devices such as drug eluting stents and catheters, along with developments in biomaterial design. The conference is aimed at academic, industrial, and regulatory scientists working in biomaterials, synthetic chemistry, natural products, devices, and formulation development, in addition to pharmaceutical and medial microbiologists. The conference is set to take place on September 24, 2009, at the headquarters of the RPSGB in London (UK).

"Devices such as central venous catheters, sutures and dressings can be designed to release antimicrobials and provide protection from associated infection during their lifetime, but this is impractical for long term devices. New strategies are needed to improve the current situation,” said Peter Lambert, Ph.D., a professor of microbiology at the University of Aston (Birmingham, UK), who will be presenting the keynote address at the conference. "Enhanced approaches into ways of improving wound healing practices are urgently required. Understanding the problem organisms of infection cause will improve the effectiveness of skin disinfectants used during surgical procedures.”

Related Links:

Royal Pharmaceutical Society of Great Britain
University of Aston




Latest Critical Care News